Clinical Trials

We at Phoenix Life Sciences want to continue the quest for helping people achieve better health through alternative healthcare. We encourage the general public to participate in ongoing study researching how cannabinoids are helping people worldwide. If you would like to contribute to science, please register for the study below.

Current Government Clinical Trials on Cannabinoids

Cannabidiol for Inflammatory Bowel Disease – Full Text …

clinicaltrials.gov/ct2/show/NCT01037322

Cannabidiol for Inflammatory Bowel Disease. … The aim of the proposed study is to examine in a double blind placebo controlled fashion the effect of …

Cannabidiol Oral Solution for The Treatment of Subjects …

clinicaltrials.gov/ct2/show/NCT02844933

The primary objectives of this study are to assess the efficacy of Cannabidiol Oral Solution on hyperphagia-related behavior in subjects with …

Sublingual Cannabidiol for Anxiety – Full Text View …

clinicaltrials.gov/ct2/show/NCT02548559

This study evaluates the effects of cannabidiol (CBD) for the treatment of anxiety in adults certified for medical marijuana. Participants will use a …

Cannabidiol Oral Solution for Treatment of Refractory …

www.clinicaltrials.gov/ct2/show/NCT02551731

To evaluate the safety of Cannabidiol Oral Solution in treating refractory infantile spasms. Part B:

Cannabidiol Expanded Access Study in Medically Refractory

clinicaltrials.gov/ct2/show/NCT02332655

Cannabidiol Expanded Access Study in Medically Refractory Sturge … and optimal dose of cannabidiol … Study in Medically Refractory Sturge-Weber

Cannabidiol and Cocaine Craving/Dependence – Full Text …

clinicaltrials.gov/ct2/show/NCT02559167

In this study, the investigators seek to evaluate the effects of cannabidiol (CBD) on cocaine craving and relapse. Cocaine addiction is characterized …

A Randomized Controlled Trial of Cannabidiol (GWP42003-P …

www.clinicaltrials.gov/ct2/show/NCT02544763

A Randomized Controlled Trial of Cannabidiol (GWP42003-P, CBD) for Seizures in Tuberous Sclerosis Complex (GWPCARE6)

Trial of Cannabidiol (CBD; GWP42003-P) for Infantile …

clinicaltrials.gov/ct2/show/NCT02953548

A Randomized, Double-blind, Placebo-controlled Trial to Investigate the Efficacy and Safety of Cannabidiol (CBD; GWP42003-P) …

Cannabidiol (CBD) and Pediatric Epilepsy – Full Text View …

www.clinicaltrials.gov/ct2/show/NCT02447198

Primary Outcome Measures: Describe the plasma pharmacokinetics of Cannabidiol (CBD), other antiepileptic drugs, Tetrahydrocannibinol (THC), and their …

A Study to Investigate the Efficacy and Safety of …

clinicaltrials.gov/ct2/show/NCT02224703

GWPCARE2 A Study to Investigate the Efficacy and Safety of Cannabidiol (GWP42003-P) in Children and Young Adults With Dravet Syndrome

Cannabidiol Oral Solution as an Adjunctive Therapy for …

www.clinicaltrials.gov/ct2/show/NCT02318537

Cannabidiol Oral Solution as an Adjunctive Therapy for Treatment of Subjects With Inadequately Controlled Lennox-Gastaut Syndrome

Study to Assess the Effect of Cannabidiol on Liver Fat …

clinicaltrials.gov/ct2/show/NCT01284634

The purpose of this study is to assess the effect of cannabidiol (CBD) on liver triglyceride (liver fat) in subjects with fatty liver disease.

Cannabidiol for Graft Versus Host Disease (GVHD …

clinicaltrials.gov/ct2/show/NCT01385124

Graft versus host disease (GVHD) … Cannabidiol is a major non-psychoactive cannabinoid, which has potent anti-inflammatory and immunosuppressive …

An Open Label Extension Study of Cannabidiol (GWP42003-P …

www.clinicaltrials.gov/ct2/show/NCT02224573

An Open Label Extension Study of Cannabidiol (GWP42003-P) in Children and Young Adults With Dravet or Lennox-Gastaut Syndromes

A Randomized Controlled Trial to Investigate Possible Drug …

clinicaltrials.gov/ct2/show/NCT02565108

A Randomized Controlled Trial to Investigate Possible Drug-drug Interactions Between Clobazam and Cannabidiol

Safety and Efficacy of Cannabidiol for Grade I/II Acute …

clinicaltrials.gov/ct2/show/NCT01596075

Cannabidiol is a major non-psychoactive cannabinoid, which has potent anti-inflammatory and immunosuppressive effects. As such, it may be effective …

A Study to Investigate the Efficacy and Safety of …

clinicaltrials.gov/ct2/show/NCT02224690

A Study to Investigate the Efficacy and Safety of Cannabidiol (GWP42003-P; CBD) as Adjunctive Treatment for Seizures Associated With Lennox-Gastaut Sy

Cannabidiol: a Novel Intervention for Cannabis Use …

clinicaltrials.gov/ct2/show/NCT02044809

The purpose of this trial is to investigate a novel treatment for cannabis dependence: cannabidiol. Between 96 and 168 young people who want to quit …

Bioequivalence Assessment of Oral Administration Vs. Oral …

clinicaltrials.gov/ct2/show/NCT01893424

Bioequivalence Assessment of Oral Administration Vs. Oral Spray of a Cannabinoids (Tetrahydrocannabinol and Cannabidiol)

A Study to Investigate the Efficacy and Safety of …

clinicaltrials.gov/ct2/show/NCT02224560

A Study to Investigate the Efficacy and Safety of Cannabidiol (GWP42003-P; CBD) as Adjunctive Treatment for Seizures Associated With Lennox-Gastaut …